Esperion Therapeutics Stock Price History
| ESPR Stock | USD 1.49 0.09 6.43% |
Below is the normalized historical share price chart for Esperion Therapeutics extending back to June 26, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Esperion Therapeutics stands at 1.49, as last reported on the 4th of August, with the highest price reaching 1.52 and the lowest price hitting 1.38 during the day.
If you're considering investing in Esperion Stock, it is important to understand the factors that can impact its price. Esperion Therapeutics appears to be very risky, given 3 months investment horizon. Esperion Therapeutics secures Sharpe Ratio (or Efficiency) of 0.15, which denotes the company had a 0.15 % return per unit of risk over the last 3 months. By reviewing Esperion Therapeutics' technical indicators, you can evaluate if the expected return of 0.83% is justified by implied risk. Please utilize Esperion Therapeutics' Coefficient Of Variation of 775.51, mean deviation of 4.44, and Downside Deviation of 4.86 to check if our risk estimates are consistent with your expectations. At this time, Esperion Therapeutics' Common Stock Total Equity is relatively stable compared to the past year. As of 08/04/2025, Common Stock Shares Outstanding is likely to grow to about 196.5 M, though Treasury Stock is likely to grow to (47 M). . As of 08/04/2025, Price Earnings To Growth Ratio is likely to grow to 0.1, while Price To Sales Ratio is likely to drop 1.18. Esperion Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of June 2013 | 200 Day MA 1.6678 | 50 Day MA 1.1382 | Beta 0.701 |
Sharpe Ratio = 0.1486
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ESPR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.57 actual daily | 49 51% of assets are more volatile |
Expected Return
| 0.83 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Esperion Therapeutics is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Esperion Therapeutics by adding it to a well-diversified portfolio.
Price Book 98.4236 | Enterprise Value Ebitda 48.7282 | Price Sales 1.0728 | Shares Float 196.3 M | Wall Street Target Price 5.7857 |
Esperion Therapeutics Stock Price History Chart
There are several ways to analyze Esperion Stock price data. The simplest method is using a basic Esperion candlestick price chart, which shows Esperion Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 28, 2025 | 1.59 |
| Lowest Price | May 14, 2025 | 0.73 |
Esperion Therapeutics August 4, 2025 Stock Price Synopsis
Various analyses of Esperion Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Esperion Stock. It can be used to describe the percentage change in the price of Esperion Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Esperion Stock.| Esperion Therapeutics Price Rate Of Daily Change | 1.06 | |
| Esperion Therapeutics Price Action Indicator | 0.09 | |
| Esperion Therapeutics Accumulation Distribution | 407,980 | |
| Esperion Therapeutics Price Daily Balance Of Power | 0.64 |
Esperion Therapeutics August 4, 2025 Stock Price Analysis
Esperion Stock Price History Data
The price series of Esperion Therapeutics for the period between Tue, May 6, 2025 and Mon, Aug 4, 2025 has a statistical range of 0.86 with a coefficient of variation of 18.75. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.08. The median price for the last 90 days is 1.09. The company completed 1:6 stock split on 11th of June 2013.| Open | High | Low | Close | Volume | ||
08/04/2025 | 1.43 | 1.52 | 1.38 | 1.49 | 4,429,497 | |
08/01/2025 | 1.39 | 1.42 | 1.34 | 1.40 | 2,637,833 | |
| 07/31/2025 | 1.38 | 1.43 | 1.36 | 1.42 | 3,293,662 | |
07/30/2025 | 1.46 | 1.52 | 1.40 | 1.41 | 4,364,108 | |
| 07/29/2025 | 1.63 | 1.63 | 1.44 | 1.47 | 4,844,668 | |
07/28/2025 | 1.55 | 1.74 | 1.50 | 1.59 | 6,185,080 | |
07/25/2025 | 1.50 | 1.58 | 1.45 | 1.51 | 5,158,430 | |
| 07/24/2025 | 1.33 | 2.08 | 1.32 | 1.49 | 34,839,056 | |
07/23/2025 | 1.24 | 1.38 | 1.21 | 1.33 | 5,549,553 | |
07/22/2025 | 1.14 | 1.24 | 1.13 | 1.22 | 3,225,484 | |
| 07/21/2025 | 1.18 | 1.22 | 1.14 | 1.15 | 1,867,557 | |
07/18/2025 | 1.25 | 1.27 | 1.14 | 1.17 | 2,933,254 | |
| 07/17/2025 | 1.12 | 1.27 | 1.11 | 1.24 | 3,626,275 | |
07/16/2025 | 1.15 | 1.16 | 1.10 | 1.12 | 2,198,320 | |
07/15/2025 | 1.18 | 1.20 | 1.12 | 1.13 | 1,794,603 | |
07/14/2025 | 1.18 | 1.21 | 1.18 | 1.18 | 1,418,061 | |
07/11/2025 | 1.23 | 1.24 | 1.17 | 1.19 | 2,092,641 | |
07/10/2025 | 1.22 | 1.25 | 1.20 | 1.24 | 2,895,393 | |
07/09/2025 | 1.18 | 1.26 | 1.17 | 1.23 | 5,010,163 | |
| 07/08/2025 | 1.12 | 1.23 | 1.11 | 1.17 | 4,637,050 | |
07/07/2025 | 1.18 | 1.18 | 1.10 | 1.11 | 2,837,682 | |
07/03/2025 | 1.17 | 1.22 | 1.15 | 1.17 | 2,321,688 | |
07/02/2025 | 1.01 | 1.18 | 1.00 | 1.15 | 5,743,304 | |
| 07/01/2025 | 0.96 | 1.04 | 0.95 | 1.00 | 2,888,923 | |
06/30/2025 | 0.99 | 1.03 | 0.98 | 0.98 | 1,496,224 | |
06/27/2025 | 1.02 | 1.06 | 0.99 | 0.99 | 4,003,148 | |
06/26/2025 | 1.01 | 1.05 | 1.00 | 1.02 | 1,794,575 | |
06/25/2025 | 1.07 | 1.08 | 1.01 | 1.01 | 1,627,463 | |
06/24/2025 | 1.06 | 1.10 | 1.03 | 1.07 | 2,572,505 | |
06/23/2025 | 1.06 | 1.08 | 0.99 | 1.04 | 3,063,757 | |
06/20/2025 | 1.10 | 1.12 | 1.05 | 1.07 | 5,151,055 | |
06/18/2025 | 1.11 | 1.13 | 1.07 | 1.10 | 2,529,581 | |
06/17/2025 | 1.15 | 1.17 | 1.08 | 1.09 | 4,490,331 | |
06/16/2025 | 1.17 | 1.20 | 1.14 | 1.17 | 2,446,001 | |
06/13/2025 | 1.18 | 1.22 | 1.16 | 1.17 | 2,145,976 | |
06/12/2025 | 1.19 | 1.21 | 1.18 | 1.20 | 1,673,643 | |
06/11/2025 | 1.24 | 1.24 | 1.18 | 1.21 | 2,928,748 | |
06/10/2025 | 1.20 | 1.24 | 1.18 | 1.22 | 2,552,129 | |
06/09/2025 | 1.21 | 1.23 | 1.13 | 1.20 | 3,762,986 | |
06/06/2025 | 1.19 | 1.27 | 1.18 | 1.22 | 5,386,778 | |
06/05/2025 | 1.13 | 1.19 | 1.08 | 1.16 | 5,090,443 | |
06/04/2025 | 1.05 | 1.13 | 1.04 | 1.12 | 5,490,147 | |
06/03/2025 | 0.94 | 1.06 | 0.91 | 1.05 | 5,764,923 | |
| 06/02/2025 | 0.85 | 0.96 | 0.85 | 0.92 | 6,059,421 | |
05/30/2025 | 0.87 | 0.87 | 0.81 | 0.85 | 4,498,312 | |
| 05/29/2025 | 0.85 | 0.88 | 0.83 | 0.87 | 3,765,990 | |
05/28/2025 | 0.81 | 0.85 | 0.79 | 0.83 | 4,150,721 | |
05/27/2025 | 0.80 | 0.83 | 0.80 | 0.82 | 4,839,946 | |
05/23/2025 | 0.80 | 0.81 | 0.76 | 0.79 | 7,358,052 | |
05/22/2025 | 0.85 | 0.87 | 0.80 | 0.80 | 3,737,089 | |
05/21/2025 | 0.91 | 0.92 | 0.84 | 0.85 | 4,501,259 | |
05/20/2025 | 0.87 | 0.92 | 0.86 | 0.91 | 6,178,278 | |
05/19/2025 | 0.81 | 0.89 | 0.80 | 0.86 | 4,271,901 | |
05/16/2025 | 0.80 | 0.81 | 0.75 | 0.80 | 4,986,477 | |
05/15/2025 | 0.73 | 0.78 | 0.69 | 0.78 | 9,238,497 | |
05/14/2025 | 0.79 | 0.80 | 0.72 | 0.73 | 7,044,616 | |
05/13/2025 | 0.81 | 0.82 | 0.75 | 0.78 | 5,925,662 | |
05/12/2025 | 0.81 | 0.86 | 0.77 | 0.80 | 12,085,540 | |
| 05/09/2025 | 0.91 | 0.93 | 0.73 | 0.80 | 11,788,060 | |
05/08/2025 | 0.87 | 0.93 | 0.84 | 0.89 | 10,082,210 | |
05/07/2025 | 0.99 | 1.00 | 0.85 | 0.87 | 6,004,357 |
About Esperion Therapeutics Stock history
Esperion Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Esperion is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Esperion Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Esperion Therapeutics stock prices may prove useful in developing a viable investing in Esperion Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 187.2 M | 196.5 M | |
| Net Loss | -210.3 M | -220.8 M |
Esperion Therapeutics Quarterly Net Working Capital |
|
Esperion Therapeutics Stock Technical Analysis
Esperion Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Esperion Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Esperion Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Esperion Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Esperion to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1101 | |||
| Jensen Alpha | 0.466 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.1263 | |||
| Treynor Ratio | 0.2956 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Esperion Stock Analysis
When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.